RxDoctor Payments Data

Kelli Williams

Nurse Practitioner · Honolulu, HINPI 1083680144

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,417 of the $3,343 with a category attached, or 72.3%. 15 manufacturers reported payments, led by Novo Nordisk at 36.6% of the total. Reporting peaked in 2021 at $1,035 and has fallen 67.6% since, to $336 in 2025. Among nurse practitioner clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,343in general payments, 2019–2025

Across 76 payments — averaging $43.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Medtronic$926
  • Boehringer Ingelheim$423
  • Abbott$255
  • Mannkind Corporation$77
  • Dexcom, Inc.$76
  • plus $361 from 9 others

What the payments were for

  • Speaking & faculty fees$83025%
  • Food & beverage$2,41772%
  • Education$973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,343 in reported general payments places this provider in the 90th percentile of 215 nurse practitioner providers in Hawaii.

See all nurse practitioner providers in Hawaii

Medicare billing

Part B allowed, 2024
$16,697
Medicare patients
206
Services billed
249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lisinopril12$319
Atorvastatin Calcium16$234
Losartan Potassium11$204
Levothyroxine Sodium14$132
Fluticasone Propionate13$113

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →